An attorney with almost three decades of experience in a wide range of legal fields, Anna Richo was named one of FiercePharma’s 2009 Top 15 Women in Pharma. Since 2012, Anna Richo has served as executive vice president and general counsel for UCB. UCB is a Belgium-based biopharmaceutical company that focuses primarily on the development of products for immunology and neurology disorders. The company has two research centers and two biotech plants in Europe, with a total research and development team of more than 1,000 individuals. UCB offers funding to outside individuals and organizations around the world who are working to raise awareness for, and expand research and improve understanding of severe diseases. UCB grants provide support to programs undertaking research into diseases such as epilepsy, Crohn’s disease, and Parkinson’s disease.
0 Comments
Leave a Reply. |
AuthorAs of November 1, 2012, Anna Richo became Executive Vice President and General Counsel of UCB, a biopharmaceutical company headquartered in Brussels, Belgium. Archives
August 2018
Categories
All
|